149 related articles for article (PubMed ID: 29230683)
1. Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center.
Savva C; Kaye P; Soomro I; Parsons SL; James E; Madhusudan S
J Gastrointest Cancer; 2018 Mar; 49(1):85-92. PubMed ID: 29230683
[No Abstract] [Full Text] [Related]
2. Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.
Plöckinger U; Wiedenmann B
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):553-76. PubMed ID: 16183527
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract.
Klöppel G; Anlauf M
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):507-17. PubMed ID: 16183524
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
[TBL] [Abstract][Full Text] [Related]
5. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metastatic disease in patients with neuroendocrine tumors.
Niederhuber JE; Fojo T
Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
[TBL] [Abstract][Full Text] [Related]
7. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal oncology].
Stiefelhagen P
Internist (Berl); 2005 Feb; 46(2):216-25. PubMed ID: 15655683
[No Abstract] [Full Text] [Related]
9. Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.
Koumarianou A; Chatzellis E; Boutzios G; Tsavaris N; Kaltsas G
Endokrynol Pol; 2013; 64(1):60-72. PubMed ID: 23450449
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine tumors of gastrointestinal tract in own material].
Myśliwiec P; Gryko M; Kedra B; Zalewski B; Kowalska I; Myśliwiec J
Endokrynol Pol; 2006; 57(2):166-71. PubMed ID: 16773593
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal cancer in the elderly.
Lichtman SM; Bayer RL
Clin Geriatr Med; 1997 May; 13(2):307-26. PubMed ID: 9115453
[TBL] [Abstract][Full Text] [Related]
12. Distribution of gastrointestinal neuroendocrine tumors: a changing paradigm.
Gross K; Richards J; Lamzabi I; Pinzon MM; Francescatti A; Brand M; Jakate S; Hayden D; Saclarides T
Am Surg; 2015 Feb; 81(2):221-3. PubMed ID: 25642890
[No Abstract] [Full Text] [Related]
13. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
Arnold R
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
[TBL] [Abstract][Full Text] [Related]
14. Mixed Adeno-Neuroendocrine Carcinoma; Case Series of Ten Patients with Review of the Literature.
Düzköylü Y; Aras O; Bostancı EB; Keklik Temuçin T; Ulaş M
Balkan Med J; 2018 May; 35(3):263-267. PubMed ID: 29551754
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors.
Stoyianni A; Pentheroudakis G; Pavlidis N
Cancer Treat Rev; 2011 Aug; 37(5):358-65. PubMed ID: 21481536
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine carcinoma of the larynx - an extraordinary malignancy with high recurrence rates and long survival: our experience in 11 patients.
van der Laan TP; van der Laan BF; Plaat BE; Wedman J; Van Hemel BM; Halmos GB
Clin Otolaryngol; 2012 Feb; 37(1):63-6. PubMed ID: 22433139
[No Abstract] [Full Text] [Related]
17. Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract.
Araki T; Takashima A; Hamaguchi T; Honma Y; Iwasa S; Okita N; Kato K; Yamada Y; Hashimoto H; Taniguchi H; Kushima R; Nakao K; Boku N; Shimada Y
Anticancer Drugs; 2016 Sep; 27(8):794-9. PubMed ID: 27341105
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
Rinke A; Gress TM
Digestion; 2017; 95(2):109-114. PubMed ID: 28161703
[TBL] [Abstract][Full Text] [Related]
19. [Neuro-endocrine tumors of the gastrointestinal tract: epidemiology, classification, prognosis, diagnosis and therapeutic modalities].
Salih HR; Hartmann JT
Praxis (Bern 1994); 2005 Feb; 94(8):291-302. PubMed ID: 15779611
[TBL] [Abstract][Full Text] [Related]
20. Large-cell neuroendocrine carcinoma of prostate. Case report.
Moratalla Charcos LM; Pastor Navarro T; Cortes Vizcaino V; Osca Garcia JM; Gil Salom M
Arch Esp Urol; 2013 May; 66(4):368-71. PubMed ID: 23676541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
